USE OF SR-90 IN THE TREATMENT OF CARCINOMA INSITU OF THE CONJUNCTIVA

被引：33

作者：

ELKON, D ^{[1
]}

CONSTABLE, WC ^{[1
]}

机构：

[1] UNIV VIRGINIA HOSP,DEPT RADIAT ONCOL,CHARLOTTESVILLE,VA 22901

来源：

AMERICAN JOURNAL OF OPHTHALMOLOGY | 1979年 / 87卷 / 01期

关键词：

D O I：

10.1016/0002-9394(79)90196-X

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Four patients with carcinoma in situ were treated with strontium-90 beta ray application. The dose used was 4,500 rads after surgical removal or with small recurrent tumor and 7,000 rads for primary treatment. All patients were disease-free at follow-up periods of 48 to 320 months after treatment. One patient required superficial x-ray treatment for recurrent disease. No serious complications developed with the treatment and no progressive cataracts have occurred. © 1979.

引用

页码：84 / 86

页数：3